Abstract
After a roller coaster ride of successes and failures, new discovery technologies and advances in manufacturing promise a brighter future for peptides in human therapy.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Evaluation of synthesized biosurfactants as promising corrosion inhibitors and alternative antibacterial and antidermatophytes agents
Scientific Reports Open Access 14 February 2023
-
The future of recombinant host defense peptides
Microbial Cell Factories Open Access 21 December 2022
-
Investigating the role of peptides in effective therapies against cancer
Cancer Cell International Open Access 27 March 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
http://www.genosys.com/prod01.html; http://www.anaspec.com/custom_fset.html.
Kelly, W.S. Therapeutic peptides: the devil is in the details. Bio/Technology 14, 28—31 ( 1996).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Latham, P. Therapeutic peptides revisited. Nat Biotechnol 17, 755–757 (1999). https://doi.org/10.1038/11686
Issue Date:
DOI: https://doi.org/10.1038/11686
This article is cited by
-
Evaluation of synthesized biosurfactants as promising corrosion inhibitors and alternative antibacterial and antidermatophytes agents
Scientific Reports (2023)
-
Investigating the role of peptides in effective therapies against cancer
Cancer Cell International (2022)
-
The future of recombinant host defense peptides
Microbial Cell Factories (2022)
-
caP4: A 2.97 KDa Cationic Antibacterial Peptide from Curcuma pseudomontana L.
International Journal of Peptide Research and Therapeutics (2020)
-
A new prokaryotic expression vector for the expression of antimicrobial peptide abaecin using SUMO fusion tag
BMC Biotechnology (2019)